Articles

With Sanofi's LixiLan® filed for FDA approval, GLP-1 agonist/basal insulin combinations may be potential game changers.

Is high cholesterol associated with risk of type 2, cardiovascular diseases and high mortality rates?

Is weight control possible in pregnant women?

The diabetes drug may have a beneficial effect on neurodegenerative diseases.

Guest Post by David Kliff, Diabetic Investor Recently we learned the identity of the new British Prime Minister, Theresa May, who, according to a post on www.jdrf.org.uk, is a type 1 diabetic. The post states: “The Home Secretary Theresa May is on course to become the first prime minister who …

The benefits of weight loss surgery for younger patients may persist for years.

Weight loss surgery helping in the reduction of type 2 diabetes, hypertension, dyslipidemia, cardiovascular disease sexual dysfunction -- even mortality rate.

Diabetes screening should be protocol test in all health centers, health fairs to prevent undiagnosed diabetes and avoid later complications.

New data presented at AACE shows hypoglycemic events are less likely in patients with diabetes treated with an electronic glycemic management system.

Novo Nordisk announced positive results on its pipeline GLP-1 candidate, semaglutide, from the phase IIIa trial, SUSTAIN 4 and 5.